Member-only story

That Elusive Influenza A Virus

Nana Dadzie Ghansah
4 min readDec 20, 2020

--

By Nana Dadzie Ghansah

Influenza Virus Hemagglutinin

One question I hear often from doubters of the COVID-19 vaccine efforts has to do with the flu vaccine:

“How come we do not have a good flu vaccine, but in 9 months, we already have a COVID-19 vaccine?”

Blame the sneakily elusive Influenza A virus.

There are four Influenza virus types — A, B, C, and D. Out of the four types, A and B are the ones that mostly cause disease in humans. The reservoir of these viruses are usually birds, but they have also been isolated from pigs and bats.

Of the two types, Influenza A is the more virulent and the one that can cause pandemics. Type B can lead to epidemics but not pandemics. We will find out shortly why.

Like most viruses, the viruses gain access to the human cell with the help of a protein. Influenza viruses use two different proteins. They are hemagglutinin and neuraminidase. Hemagglutinin gets it into the cell, where it replicates. After replication, it needs neuraminidase to get it out to invade other cells. Hemagglutinin is the protein vaccines target.

Now the Influenza A virus has sixteen subtypes of the hemagglutinin (H1 to H16) and nine types of neuraminidase (N1 — N9) proteins. (Recently, subtypes H17 — H18 and N10- N11 were isolated from bats ).

--

--

Nana Dadzie Ghansah
Nana Dadzie Ghansah

Written by Nana Dadzie Ghansah

An anesthesiologist, photographer, writer, and poet. He lives and works in Lexington, Kentucky.

No responses yet